MERCK KGAA |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 168.55 EUR | -0.74% |
|
-0.82% | +16.97% |
| 09-09 | German Shares Cheer Likelihood of September ECB Rate Cut | MT |
| 09-03 | Merck Gets EU Approval for Keytruda Cancer Therapy | DJ |
EPS & Dividend: Merck KGaA
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | 1.3 | 1.4 | 1.85 | 2.2 | 2.2 | 2.306 | 2.573 | 2.751 |
| Rate of return | 1.23% | 1% | 0.81% | 1.22% | 1.53% | 1.37% | 1.53% | 1.63% |
| EPS 2 | 3.04 | 4.57 | 7.03 | 7.65 | 6.49 | 6.875 | 8.223 | 9.071 |
| Distribution rate | 42.8% | 30.6% | 26.3% | 28.8% | 33.9% | 33.5% | 31.3% | 30.3% |
| Reference price 2 | 105.35 | 140.35 | 227.00 | 180.90 | 144.10 | 168.55 | 168.55 | 168.55 |
| Nbr of stocks (in thousands) | 434,778 | 434,778 | 434,778 | 434,778 | 434,778 | 434,778 | - | - |
| Announcement Date | 20-03-05 | 21-03-04 | 22-03-03 | 23-03-02 | 24-03-07 | - | - | - |
1EUR in Million2EUR
Estimates
Past dividends: Merck KGaA
| 2024-04-28 | Annual 2.2 EUR |
| 2023-05-01 | Annual 2.2 EUR |
| 2022-04-24 | Annual 1.85 EUR |
| 2021-04-25 | Annual 1.4 EUR |
| 2020-05-28 | Annual 1.3 EUR |
| 2019-04-28 | Annual 1.25 EUR |
| 2018-04-29 | Annual 1.25 EUR |
| 2017-05-01 | Annual 1.2 EUR |
| 2016-05-01 | Annual 1.05 EUR |
| 2015-04-19 | Annual 1 EUR |
Upcoming events: Merck KGaA
More events
| Yield (Y) | Yield (Y+1) | P/E ratio | Price to Book | EV / Sales | ||
|---|---|---|---|---|---|---|
| +1.36% | +1.52% | 24.7x | 2.558 | 3.77x | ||
| +1.81% | +1.89% | 24.95x | 2.000 | 2.8x | ||
| +0.35% | +0.35% | 60.04x | 4.332 | 4.34x | ||
| -.--% | -.--% | 109.64x | 21.68 | 14.55x | ||
| +0.65% | +0.97% | 34.62x | 2.924 | 6.21x | ||
| +17.58% | +20.02% | 11.38x | 1.058 | - | ||
| - | - | 29.66x | 6.220 | - | ||
| - | - | 107.17x | - | - | ||
| - | - | - | - | - | ||
| +0.74% | +0.89% | 17.45x | 2.106 | - | ||
| Average | +3.21% | +3.66% | 46.63x | 5.36 | 6.34x | |
| Weighted average by Cap. | +1.53% | +1.71% | 32.31x | 3.63 | 4.33x |
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Estimates Revisions:
More analyst reviews
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition